+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncology Nutrition Market by Product Type, Route of Administration, Cancer Type, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Oncology Nutrition Market by Product Type, Route of Administration, Cancer Type, Age Group, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Oncology Nutrition Market by Product Type, Route of Administration, Cancer Type, Age Group, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968763
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Oncology Nutrition Market is projected to reach USD 3.22 Billion in 2026. It is expected to continue growing at a CAGR of 8.22%, reaching USD 5.20 Billion by 2032.

Oncology nutrition is becoming a core component of cancer care as health systems confront a rising global cancer burden and the clinical consequences of malnutrition, cachexia, sarcopenia, treatment intolerance, and reduced quality of life. The International Agency for Research on Cancer reported nearly 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, with cases projected to exceed 35 million by 2050. This expanding patient population is increasing demand for evidence-based nutrition screening, oral nutritional supplements, enteral and parenteral nutrition, immunonutrition, and digitally enabled dietetic support across the cancer care continuum.

The oncology nutrition market is shaped by a strong clinical rationale: cancer-associated malnutrition is reported across tumor types and care settings, with higher prevalence in gastrointestinal, head and neck, lung, pancreatic, and advanced-stage cancers. International clinical guidance, including recommendations from ESPEN and oncology nutrition societies, emphasizes routine nutrition risk screening, early intervention, individualized protein and energy targets, symptom management, and multidisciplinary coordination. As oncology shifts toward precision medicine, cancer nutrition is also moving from supportive care to an integrated strategy that can help preserve functional status, improve treatment completion, and support survivorship outcomes.

Transformative Shifts in the Oncology Nutrition Landscape

The oncology nutrition landscape is being transformed by earlier nutrition screening, greater attention to muscle preservation, and a shift from reactive feeding support to proactive, personalized care. Cancer centers are increasingly embedding registered dietitians into tumor boards, infusion centers, radiation oncology pathways, and survivorship clinics to address nutrition-impact symptoms such as dysphagia, mucositis, nausea, altered taste, anorexia, diarrhea, constipation, and fatigue before they compromise therapy adherence.

Product innovation is also accelerating across high-protein oral nutritional supplements, omega-3-enriched formulas, diabetes-specific formulations, elemental and semi-elemental feeds, and modular protein products designed for complex oncology needs. At the same time, home-based care, remote patient monitoring, and hospital-at-home models are expanding demand for nutrition solutions that are clinically reliable, easy to administer, reimbursable, and compatible with multidisciplinary follow-up. Regulatory expectations around substantiation, safety, labeling, and medical claims remain a defining factor for competitive differentiation.

Cumulative Impact of Artificial Intelligence on Oncology Nutrition

Artificial intelligence is beginning to reshape oncology nutrition through risk stratification, workflow automation, and personalization. AI-enabled tools can analyze electronic health records, laboratory results, weight trends, treatment regimens, patient-reported outcomes, and imaging-derived body composition markers to identify patients at elevated risk of malnutrition or sarcopenia. These applications are especially relevant because weight alone can mask muscle loss in patients with obesity, edema, or fluid retention.

The cumulative impact of AI is expected to be strongest where it supports clinicians rather than replaces them. Predictive analytics can prompt earlier dietitian referrals, flag nutrition-impact toxicities, optimize follow-up intervals, and support adherence monitoring for oral supplements or tube feeding regimens. However, adoption depends on transparent model validation, bias mitigation, data privacy compliance, integration with oncology workflows, and alignment with medical device and clinical decision support regulations. Organizations that combine AI with evidence-based oncology nutrition protocols will be better positioned to demonstrate measurable improvements in patient experience, operational efficiency, and continuity of care.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is a high-potential region for oncology nutrition because it combines a large and aging population, rising cancer incidence, expanding private healthcare, and increasing access to modern oncology services. China, India, Japan, South Korea, and Australia are strengthening cancer screening and treatment infrastructure, while nutrition support is gaining visibility in surgical oncology, chemoradiation, and survivorship. Japan and South Korea show strong clinical adoption of specialized medical nutrition and aging-related care models, while India and Southeast Asia continue to balance rapid demand growth with affordability, awareness, and access constraints.

North America remains one of the most mature oncology nutrition environments due to advanced cancer networks, strong dietitian integration, clinical guideline adoption, patient assistance programs, and broad availability of specialized oral and enteral nutrition products. Europe is similarly guideline-driven, with the European Union emphasizing quality standards, clinical nutrition research, and cross-border regulatory consistency, while the United Kingdom, Germany, France, Italy, and Spain maintain strong institutional oncology care pathways. Latin America, led by Brazil and Mexico, is expanding oncology capacity, but uneven reimbursement and public-sector resource constraints affect access to specialized nutrition. The Middle East, particularly GCC countries, is investing in cancer centers and medical nutrition services, while Africa faces the dual challenge of rising cancer burden and undernutrition, making scalable screening, affordable supplementation, reliable procurement, and workforce development critical.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN presents a diverse oncology nutrition opportunity, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines at different stages of oncology infrastructure maturity. Urban private hospitals are adopting specialized nutrition services faster, while public systems need cost-effective products, clinical training, and screening tools that can scale across high-volume settings. GCC countries are advancing through government investment in cancer care, high rates of diabetes and obesity that complicate nutrition planning, and growing demand for premium clinical nutrition in hospital and homecare settings.

The European Union provides a favorable environment for evidence-based oncology nutrition because of harmonized food and medical nutrition regulations, strong clinical nutrition societies, and structured cancer policy initiatives. BRICS countries represent a large-volume opportunity driven by population scale, cancer incidence, local manufacturing potential, and expanding oncology coverage, though affordability and regional disparities remain decisive. G7 markets lead in research intensity, clinical protocol development, reimbursement sophistication, digital health integration, and premium product adoption. NATO countries, while not a healthcare market bloc, are increasingly relevant to supply-chain resilience, medical readiness, and procurement stability for critical nutrition products used in hospitals, emergency care, and complex chronic disease management.

Key Country Insights Across Major Oncology Nutrition Markets

The United States leads in oncology nutrition innovation through comprehensive cancer centers, strong clinical trial activity, digital health adoption, and broad availability of oral, enteral, and parenteral nutrition products, although reimbursement complexity and disparities in dietitian access remain persistent challenges. Canada benefits from universal healthcare structures and cancer agency coordination, while Mexico is expanding oncology services but faces uneven access between public and private systems. Brazil is the largest Latin American opportunity, supported by a sizable cancer population and hospital nutrition demand, while access and funding variability continue to shape adoption of specialized cancer nutrition supplements and enteral nutrition in cancer care.

In Europe, the United Kingdom emphasizes integrated cancer pathways and survivorship support, Germany combines strong hospital infrastructure with clinical nutrition adoption, and France maintains a well-developed oncology system with attention to supportive care. Italy and Spain continue to advance nutrition screening and geriatric oncology practices, while Russia presents a large patient base with regional differences in access and procurement. In Asia-Pacific, China is scaling oncology infrastructure rapidly and building domestic medical nutrition capabilities; India has high demand potential but requires affordability, awareness, and distribution expansion; Japan’s aging population supports advanced clinical nutrition integration; Australia benefits from guideline-based supportive care; and South Korea combines high healthcare digitization with sophisticated cancer treatment pathways.

Actionable Recommendations for Oncology Nutrition Industry Leaders

Industry leaders should prioritize clinically validated, oncology-specific nutrition solutions that address protein adequacy, muscle preservation, gastrointestinal tolerance, metabolic complications, and therapy-related symptoms. Organizations that invest in real-world evidence, health economic studies, and outcomes linked to treatment completion, hospital length of stay, readmissions, adverse event management, and patient-reported quality of life will be better positioned with payers, providers, and cancer centers.

Commercial strategy should combine product innovation with service models. This includes dietitian education, nutrition screening tool integration, digital adherence support, multilingual patient resources, and partnerships with oncology networks, homecare providers, and patient advocacy organizations. Leaders should also localize portfolios by region: premium specialized formulas may perform well in mature markets, while affordable high-protein supplements, modular products, and scalable screening programs are essential in emerging markets. Supply-chain resilience, regulatory compliance, clinical substantiation, and ethical AI governance should be treated as strategic priorities rather than back-office functions.

Research Methodology

This executive summary is based on a structured secondary research methodology using publicly available, authoritative sources, including cancer epidemiology from IARC and WHO, clinical nutrition guidance from ESPEN and oncology nutrition organizations, national cancer agencies, peer-reviewed literature, regulatory frameworks, and healthcare policy publications. Market interpretation was developed by triangulating disease burden, nutrition risk evidence, oncology care infrastructure, reimbursement conditions, product adoption patterns, and regional healthcare investment trends.

Insights were evaluated for consistency across multiple data sources and framed to avoid unsupported market sizing or speculative claims. Qualitative assessment included clinical pathway analysis, regional access dynamics, digital health readiness, and the role of multidisciplinary cancer care. The methodology emphasizes data-backed interpretation, practical relevance, and focused clarity for stakeholders evaluating the oncology nutrition market, cancer nutrition supplements, enteral nutrition in cancer care, immunonutrition, oncology dietitian services, and personalized nutrition for oncology patients.

Conclusion

Oncology nutrition is entering a more strategic phase as cancer care becomes more personalized, multidisciplinary, and outcomes-focused. The strongest opportunities will emerge where nutrition is integrated early, measured consistently, and connected to treatment tolerance, functional preservation, and survivorship. Rising cancer incidence, aging populations, and growing recognition of malnutrition, sarcopenia, and cachexia are creating sustained demand for specialized nutrition products and services.

The competitive landscape will reward organizations that combine clinical credibility, patient-centered design, digital enablement, regional affordability, and evidence generation. As AI, homecare, and precision oncology evolve, nutrition will become increasingly important to comprehensive cancer care. Organizations that align innovation with guidelines, reimbursement realities, and equitable access will be best positioned to lead the global oncology nutrition market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Oncology Nutrition Market, by Product Type
7.1. Enteral Nutrition
7.1.1. Elemental Formulas
7.1.2. Modular Formulas
7.1.3. Standard Formulas
7.2. Oral Nutritional Supplements
7.2.1. Disease Specific
7.2.2. High Protein
7.2.3. Immunonutrition
7.3. Parenteral Nutrition
7.3.1. Supplemental Parenteral Nutrition
7.3.2. Total Parenteral Nutrition
8. Oncology Nutrition Market, by Route Of Administration
8.1. Enteral
8.2. Oral
8.3. Parenteral
9. Oncology Nutrition Market, by Cancer Type
9.1. Breast Cancer
9.2. Gastrointestinal Cancer
9.3. Head & Neck Cancer
9.4. Hematologic Malignancies
9.5. Lung Cancer
9.6. Gynecologic Cancer
10. Oncology Nutrition Market, by Age Group
10.1. Pediatric
10.2. Adult
10.3. Geriatric
11. Oncology Nutrition Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Retail
11.3. Retail Pharmacies
11.4. Specialty Clinics
12. Asia-Pacific Oncology Nutrition Market
13. North America Oncology Nutrition Market
14. Latin America Oncology Nutrition Market
15. Europe Oncology Nutrition Market
16. Middle East Oncology Nutrition Market
17. Africa Oncology Nutrition Market
18. ASEAN Oncology Nutrition Market
19. GCC Oncology Nutrition Market
20. European Union Oncology Nutrition Market
21. BRICS Oncology Nutrition Market
22. G7 Oncology Nutrition Market
23. NATO Oncology Nutrition Market
24. United States Oncology Nutrition Market
25. Canada Oncology Nutrition Market
26. Mexico Oncology Nutrition Market
27. Brazil Oncology Nutrition Market
28. United Kingdom Oncology Nutrition Market
29. Germany Oncology Nutrition Market
30. France Oncology Nutrition Market
31. Russia Oncology Nutrition Market
32. Italy Oncology Nutrition Market
33. Spain Oncology Nutrition Market
34. China Oncology Nutrition Market
35. India Oncology Nutrition Market
36. Japan Oncology Nutrition Market
37. Australia Oncology Nutrition Market
38. South Korea Oncology Nutrition Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Abbott Laboratories
40.2. ADM Human Nutrition
40.3. Ajinomoto Co., Inc.
40.4. Arla Foods Ingredients Group P/S
40.5. B. Braun Melsungen AG
40.6. Baxter International Inc.
40.7. Danone S.A.
40.8. Fresenius Kabi AG
40.9. Global Health Products, Inc.
40.10. Hormel Foods Corporation
40.11. Kerry Group plc
40.12. Lonza Group AG
40.13. Mead Johnson Nutrition Company, LLC
40.14. Meiji Holdings Co., Ltd.
40.15. Nestlé Health Science S.A.
40.16. Otsuka Pharmaceutical Co., Ltd.
40.17. Perrigo Company plc
40.18. Rousselot B.V.
40.19. Tate & Lyle plc
40.20. Victus, Inc.
40.21. Vitaflo International Ltd.
40.22. Yakult Honsha Co., Ltd.
List of Figures
FIGURE 1. GLOBAL ONCOLOGY NUTRITION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ONCOLOGY NUTRITION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ONCOLOGY NUTRITION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ONCOLOGY NUTRITION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ONCOLOGY NUTRITION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ELEMENTAL FORMULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ELEMENTAL FORMULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ELEMENTAL FORMULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MODULAR FORMULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MODULAR FORMULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MODULAR FORMULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STANDARD FORMULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STANDARD FORMULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STANDARD FORMULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ORAL NUTRITIONAL SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ORAL NUTRITIONAL SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ORAL NUTRITIONAL SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HIGH PROTEIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HIGH PROTEIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HIGH PROTEIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNONUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNONUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNONUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SUPPLEMENTAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SUPPLEMENTAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SUPPLEMENTAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEAD & NECK CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEAD & NECK CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEAD & NECK CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GYNECOLOGIC CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GYNECOLOGIC CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GYNECOLOGIC CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ONLINE RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ONLINE RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ONLINE RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 151. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 152. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 153. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 154. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. GCC ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GCC ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. GCC ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 160. GCC ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 161. GCC ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 162. GCC ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. GCC ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 165. GCC ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 178. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 179. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 180. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 181. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 183. BRICS ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. G7 ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. G7 ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. G7 ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 187. G7 ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 188. G7 ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 189. G7 ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. G7 ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 192. G7 ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. NATO ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. NATO ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. NATO ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 196. NATO ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 197. NATO ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 198. NATO ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199. NATO ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 201. NATO ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. CANADA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 214. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 215. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 216. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 217. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 218. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 219. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. MEXICO ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 223. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 224. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 225. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 226. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 227. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 228. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 232. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 233. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 234. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 235. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 237. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. GERMANY ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 250. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 251. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 252. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 253. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 254. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 255. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 256. FRANCE ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 259. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 260. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 261. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 263. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 264. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 267. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 268. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 269. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 270. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 271. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 272. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 273. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. ITALY ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 277. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 278. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 279. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 280. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 281. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 282. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. SPAIN ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 286. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 287. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 288. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 290. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 291. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. CHINA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 295. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 296. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 297. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 298. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 299. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 300. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 301. INDIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 303. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 304. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 305. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 306. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 307. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 308. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 309. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 310. JAPAN ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 312. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 313. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 314. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 315. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 316. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 317. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 318. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 319. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 321. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 322. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 323. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 324. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 325. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 326. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 327. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 328. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 330. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 331. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ORAL NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 332. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
TABLE 333. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 334. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 335. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 336. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Oncology Nutrition market report include:
  • Abbott Laboratories
  • ADM Human Nutrition
  • Ajinomoto Co., Inc.
  • Arla Foods Ingredients Group P/S
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Danone S.A.
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Kerry Group plc
  • Lonza Group AG
  • Mead Johnson Nutrition Company, LLC
  • Meiji Holdings Co., Ltd.
  • Nestlé Health Science S.A.
  • Otsuka Pharmaceutical Co., Ltd.
  • Perrigo Company plc
  • Rousselot B.V.
  • Tate & Lyle plc
  • Victus, Inc.
  • Vitaflo International Ltd.
  • Yakult Honsha Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.2 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Clinical Nutrition for Cancer Care Market - Global Strategic Business Report - Product Image

Clinical Nutrition for Cancer Care Market - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Clinical Nutrition for Cancer Care Market Report 2026 - Product Image

Clinical Nutrition for Cancer Care Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Oncology Nutrition - Global Strategic Business Report - Product Image

Oncology Nutrition - Global Strategic Business Report

  • Report
  • 352 Pages
  • Global
From
Oncology Nutrition Market Report 2026 - Product Image

Oncology Nutrition Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cancer Cachexia Market - Global Forecast 2026-2032 - Product Image

Cancer Cachexia Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.